Pharmaceutical Research

Immunotherapy and Immuno-Oncology

Immunotherapy and Immuno-Oncology are revolutionary subjects at the forefront of cancer treatment, harnessing the power of the immune system to combat cancer cells. This subject explores innovative therapeutic approaches that stimulate or modulate the immune response to target and eliminate cancer cells selectively. The subject delves into various immunotherapies, including immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and adoptive T cell therapy. It explores the mechanisms of action and clinical applications of these therapies, both as Monotherapies and in combination with other treatments. The conference on Immunotherapy and Immuno-Oncology brings together leading scientists, oncologists, and immunologists to share cutting-edge research and clinical insights. By fostering interdisciplinary discussions and knowledge exchange, this subject aims to accelerate the development and implementation of immunotherapies, paving the way for transformative treatments and improved outcomes for cancer patients.